Low propidium iodide intensity in flow cytometric white blood cell counting as a marker of cell destruction?

Transfusion

Volumn 45, Issue 2, 2005, Pages 228-233

  Wagner, Thomas ^a   Guber, Sylvia E ^b   Stubenrauch, Maria Luise ^b   Lanzer, Gerhard ^b   Neumueller, Josef ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; PROPIDIUM IODIDE;

ARTICLE; BLOOD FILTRATION; CELL DESTRUCTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA DEGRADATION; ERYTHROCYTE PRESERVATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE COUNT; NORMAL HUMAN; TRANSMISSION ELECTRON MICROSCOPY;

BIOLOGICAL MARKERS; BLOOD COMPONENT REMOVAL; BLOOD COMPONENT TRANSFUSION; FLOW CYTOMETRY; HEMATOCRIT; HEMOGLOBINS; HUMANS; INDICATORS AND REAGENTS; LEUKOCYTE COUNT; LEUKOCYTES; PROPIDIUM;

EID: 13144288980     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.04213.x     Document Type: Article

References (24)

1. Williamson LM, Wimperis JZ, Williamson P, et al. Bedside filtration of blood products in the prevention of HLA alloimmunization: a prospective randomised trial. Blood 1994;83:3028-35.
2. Leukocyte reduction and ultraviolet irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997;337:1861-9.
3. Bordin JA, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994;84:1703-21.
4. Uhlmann EJ, Isgriggs E, Wallhermfechtel M, Goodnough LT. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion 2001;41:997-9.
5. Bowden RA, Sayers M, Fluornoy N, et al. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 1986;314:1006-10.
6. Miller WJ, McCullough J, Balfour HH, et al. Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening. Bone Marrow Transplant 1991;7:227-34.
7. Preiksaitis JK. The cytomegalovirus-"safe" blood product: is leukoreduction equivalent to antibody screening? Transfus Med Rev 2000;14:112-36.
8. Nichols WG, Price TH, Gooley T, Corey L, Boeckh M. Transfusion- transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood 2003;101:4195-200.
9. Guide to the preparation, use, and quality assurance of blood components. 9th ed. Brussels: Council of Europe Publishing; 2003.
10. Janatpour K, Paglieroni TG, Schuller L, et al. Interpretation of atypical patterns encountered when using a flow cytometry-based method to detect residual leukocytes in leukoreduced red blood cell components. Cytometry 2002;50:254-60.
11. Tazzari PL, Bontadini A, Fruet F, et al. Flow cytometry characterization of white cell-reduced blood: apoptosis markers and morphology of postfiltration elements. Vox Sang 2003;85:109-13.
12. Wagner T, Vetter A, Dimovic N, et al. Ultrastructural changes and activation differences in platelet concentrates stored in plasma and additive solution. Transfusion 2002;42:719-27.
13. Wagner T, Oberkanins C, Weinmayr B, et al. HLA-B*27 typing by group-specific hybridization in microtiter plates. Tissue Antigens 1998;52:175-8.
14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
15. Stoddart CA, Cardin RD, Boname JM, et al. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol 1994;68:6243-53.
16. Soderberg-Naucler C, Fish KN, Nelson JA. Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus- permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J Clin Invest 1997;100:3154-63.
17. Luppi M, Torelli G. The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: an overview. Haematologica 1996;81:265-81.
18. Manez R, Breinig MK, Linden P, et al. Factors associated with the development of post-transplant lymphoproliferative disease (PTLD) in Epstein-Barr virus (EBV)-seronegative adult liver transplant recipients. Transpl Int 1994;7(Suppl 1):S235-7.
19. Zucker-Franklin D, Pancake BA. White cell reduction by filtration may significantly decrease human T-lymphotropic virus type 1 Tax sequences and Tax-encoded proteins in blood used for transfusion. Transfusion 1998;38:317-8.
20. Dodd RY. Current risks of blood and blood products. Ann Med 2000;32:469-74.
21. Frabetti F, Musiani D, Marini M, et al. White cell apoptosis in packed red cells. Transfusion 1998;38:1082-9.
22. Snyder EL, Kuter DJ. Apoptosis in transfusion medicine: of death and dying - is that all there is? Transfusion 2000;40:135-8.
23. Martelli AM, Tazzari PL, Bortul R, et al. Nuclear matrix protein is released from apoptotic white cells during cold (16°C) storage of concentrated red cell units and might induce antibody response in multiple transfused patients. Transfusion 2000;40:169-77.
24. Bontadini A, Tazzari PL, Manfroi S, Tassi C, Conte R. Apoptosis in leukodepleted packed red cells. Vox Sang 2002;83:35-41.